President Trump's executive order reclassifying marijuana from Schedule I to Schedule III under the Controlled Substances Act is the most significant shift in federal cannabis drug policy in decades. For cannabis businesses that have spent years navigating hostile banking relationships, limited payment options, and punishing tax treatment under Section 280E, the development carries real weight. […]

